Life Science Nation Newsletter  |  March 17, 2016  |  Issue 154
  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Accelerator
Life Science Investor Mandates (Mar. 10 - Mar. 16)
Seeks Therapeutic Opportunities Worldwide
Seeks Therapeutics In Oncology, Regenerative Medicine, Inflammatory, and Immune Disorders
Seeks HCIT, Diagnostics and Life Science Tools
Raises New Fund for Innovative Therapeutics, Medtech, Diagnostics
In This Issue
Nature BioEntrepreneur Features LSN: Aligning Needs
LSN Videos
RESI San Francisco 2016 Investors Panel

Video Recap of RESI@TMCx 2015

By  Shaoyu Chang, MD, MPH, Senior Research Manager, LSN

It's time to announce the successful applicants to the RESI@TMCx Innovation Challenge. LSN's scientific review board have assessed and ranked all entrants across a wide range of criteria, from scientific novelty to strength of IP, to select the 30 strongest entrants. These entrepreneurs will receive a presentation space in the RESI@TMCx exhibit hall for the full day of the conference to showcase their innovations to investors and fellow entrepreneurs. All RESI attendees have the opportunity to vote in the Innovation Challenge by "investing" in the best of these companies.

If your company missed this opportunity to compete in the RESI@TMCx Innovation Challenge, you can now enter the RESI on MaRS Innovation Challenge, to be held on June 23rd in Toronto...

By Jay Doherty, Business Development, LSN

Like many players in healthcare, the Life Science Nation team travel around the world to attend partnering conferences and build dialogue with investors and fundraising CEOs. We've had the opportunity to see both the best and the worst in partnering, and have also heard from investors about what catches their attention in a partnering message. Last year, LSN provided a template partnering message designed to increase your response rate when reaching out to investors. Here are some additional tips for successful partnering requests:

Be brief and concise in your outreach. Investors want to see enough information to entertain a meeting...

By Lucy Parkinson, Director of Research, LSN

With the explosion of activity in early stage life sciences in the last few years, many new programs have been formed to support the youngest new biotech, medtech and healthcare IT companies in developing their products and making first steps toward commercialization.

This RESI panel will highlight five programs that provide vital resources at the earliest stage, including support, work space, mentoring, business education, and investment. The panelists will talk about how they select companies, how they help entrepreneurs turn scientific ideas into commercial success stories, and what makes each of their programs unique.

Moderated by Atul Varadhachary, Managing Partner, Fannin Innovation Studio, this session will feature:
  • David E. Huizenga, Co-Founder, President & CEO, TAO Life Sciences
  • Blair Kessler, Manager, Healthbox
  • Dianne Carmichael, Managing Director, MaRS Discovery District
  • Hubert Zajicek, CEO, Health Wildcatters

Life Science Nation | 9B Hamilton Place | Boston | MA | 02108